open access
Eales’ disease
Affiliations- Laser Plus Eye, Nea Smyrni, Athens, Greece
open access
Abstract
This is a case report of a patient diagnosed with Eales’ disease. Characteristics, etiology and symptoms will be described
in this study. Moreover, we will present case of a 61-year-old woman and discuss the clinical features, treatment
plan and its outcome in our patient.
Abstract
This is a case report of a patient diagnosed with Eales’ disease. Characteristics, etiology and symptoms will be described
in this study. Moreover, we will present case of a 61-year-old woman and discuss the clinical features, treatment
plan and its outcome in our patient.
Keywords
Eales’ disease; vitreous haemorrhage; floaters
About this articleTitle
Eales’ disease
Journal
Issue
Vol 4 (2019): Continuous Publishing
Article type
Case report
Pages
28-30
Published online
2019-05-21
Page views
545
Article views/downloads
670
DOI
Bibliographic record
Ophthalmol J 2019;4:28-30.
Keywords
Eales’ disease
vitreous haemorrhage
floaters
Authors
Ioannis Mallias
Panagiota Petrakogianni
References (12)- Patnaik B, Nagpal P, Namperumalsamy P, et al. Eales disease – clinical features, pathophysiology, ethiopathogenesis. Ophthalmol Clin North Am. 1998; 11(4): 601–617.
- Biswas J, Ravi RK, Naryanasamy A, et al. Eales' disease — current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013; 3(1): 11.
- Nicolcescu A, Mocanu C, Dinu L, et al. Unilateral Eales’ disease a case report. Rom J Ophthalmol. 2017; 61(2): 144–149.
- Gupta SR, Flaxel CJ. The use of a vascular endothelial growth factor inhibitor (ranibizumab) in macular edema due to eales disease. Retin. Cases Brief Rep. 2012; 6(1): 122–124.
- Belmokhtar A, Daoudi R. Eales disease: no typical clinical presentation. Pan Afr Med J. 2014; 17: 136.
- Jacobiec FA, Albert DM. Atlas of clinical ophthalmology. Saunders, Philadelphia 1996.
- Agrawal S, Agrawal J, Agrawal TP. Intravitreal triamcinolone acetonide in Eales disease. Retina. 2006; 26(2): 227–229.
- Patwardhan S, Azad R, Shah B, et al. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study. Retina. 2011; 31(5): 866–870.
- Paine SK, Sen A, Chowdhury IH, et al. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease. Retina. 2011; 31(7).
- Das T, Pathengay A, Hussain N, et al. Eales' disease: diagnosis and management. Eye (Lond). 2010; 24(3): 472–82.
- Roy FH, Randall J, Fraunfelder FT. Current Ocular Therapy. Elsevier/Saunders, Philadephia 2008: 624–625.
- Fraunfelder FT, Randall J, Roy FH. Current Ocular Therapy. Saunders Company, Philadephia 2000: 609–611.